Can bioadhesive nanoparticles allow for more effective particle uptake from the small intestine?

被引:41
作者
Reineke, J. [1 ]
Cho, D. Y. [2 ]
Dingle, Y. L. [2 ]
Cheifetz, P. [2 ]
Laulicht, B. [2 ]
Lavin, D. [2 ]
Furtado, S. [2 ]
Mathiowitz, E. [2 ]
机构
[1] Wayne State Univ, Dept Pharmaceut Sci, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI 48202 USA
[2] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA
关键词
Bioadhesion; Nanoparticles; Uptake; In-vitro in-vivo correlation; CONTROLLED DRUG-DELIVERY; ORAL DELIVERY; MICROSPHERES; MUCOADHESIVE; POLYMERS; ABSORPTION; BIOAVAILABILITY; PLATFORMS; SYSTEMS;
D O I
10.1016/j.jconrel.2013.05.043
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
There has been increasing interest in developing bioadhesive nanoparticles due to their great potential as carriers for therapeutics in oral drug delivery systems. Despite decades of research, such a system still has not been successfully implemented. This paper demonstrates the enormous potential of such engineered systems: the incorporation of a bioadhesive coating, poly(butadiene-maleic anhydride-co-L-DOPA) (PBMAD), to non-bioadhesive nanospheres resulted in an enhancement of particle uptake in the small intestine from 5.8 +/- 1.9% to 66.9 +/- 12.9%. Direct correlation was obtained between bulk tensile strength, in vitro binding to everted intestinal sacs and quantitative in vivo uptake; this data suggests that bulk properties of polymers can be used to predict bioadhesive properties of nano-and microparticles. The differential distribution of the nanospheres to various tissues following uptake suggests surface chemistry plays a significant role in their localization within the body. The results of these studies provide strong support for the use of bioadhesive polymers to enhance nano-and micro-particle uptake from the small intestine for oral drug delivery. (C) 2013 Elsevier B. V. All rights reserved.
引用
收藏
页码:477 / 484
页数:8
相关论文
共 44 条
[1]   Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties [J].
Arbós, P ;
Campanero, MA ;
Arnangoa, MA ;
Renedo, MJ ;
Irache, JM .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (01) :19-30
[2]  
Carino G.P., 1999, BIOADHESIVE DRUG DEL
[3]   Nanosphere based oral insulin delivery [J].
Carino, GP ;
Jacob, JS ;
Mathiowitz, E .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :261-269
[4]  
Chickering D, 1996, BIOTECHNOL BIOENG, V52, P96, DOI 10.1002/(SICI)1097-0290(19961005)52:1<96::AID-BIT9>3.0.CO
[5]  
2-U
[6]   BIOADHESIVE MICROSPHERES .2. CHARACTERIZATION AND EVALUATION OF BIOADHESION INVOLVING HARD, BIOERODIBLE POLYMERS AND SOFT-TISSUE [J].
CHICKERING, DE ;
JACOB, JS ;
MATHIOWITZ, E .
REACTIVE POLYMERS, 1995, 25 (2-3) :189-206
[7]   BIOADHESIVE MICROSPHERES .1. A NOVEL ELECTROBALANCE-BASED METHOD TO STUDY ADHESIVE INTERACTIONS BETWEEN INDIVIDUAL MICROSPHERES AND INTESTINAL-MUCOSA [J].
CHICKERING, DE ;
MATHIOWITZ, E .
JOURNAL OF CONTROLLED RELEASE, 1995, 34 (03) :251-262
[8]   Bioadhesive microspheres .3. An in vivo transit and bioavailability study of drug-loaded alginate and poly(fumaric-co-sebacic anhydride) microspheres [J].
Chickering, DE ;
Jacob, JS ;
Desai, TA ;
Harrison, M ;
Harris, WP ;
Morrell, CN ;
Chaturvedi, P ;
Mathiowitz, E .
JOURNAL OF CONTROLLED RELEASE, 1997, 48 (01) :35-46
[9]  
Chickering Donald E. Iii, 1995, Biomedical Instrumentation and Technology, V29, P501
[10]   Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach [J].
des Rieux, Anne ;
Fievez, Virginie ;
Garinot, Marie ;
Schneider, Yves-Jacques ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (01) :1-27